Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Magen-Darm » IBD (Crohn/Colitis) 26. Mai 2020
Suchen
Gastroplattform
IBD (Crohn/Colitis)
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Diarrhoe
IBD (Crohn/Colitis)
Funktionelle Beschwerden
Gastroenteritis
GI-Blutung
Neoplasie
Peptisches Ulkus
Anderes
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1869  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 37372  
   
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.
Adv Ther
Sandborn WJ, Vermeire S, Tyrrell H, Hassanali A, Lacey S, Tole S, Tatro AR, Etrolizumab Global Steering Committee..
PMID: 32445184 [PubMed - as supplied by publisher]


Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk.
Dig Dis Sci
Cui Y, Zhang J, Chen Y, Chen LG.
PMID: 32445051 [PubMed - as supplied by publisher]


Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors.
Clin Exp Gastroenterol
Troncone E, Marafini I, Del Vecchio Blanco G, Di Grazia A, Monteleone G.
PMID: 32440190 [PubMed]


Interleukin-1β as a Predictor of Glucocorticoid Response in Ulcerative Colitis.
Digestion
Okuno H, Ogino H, Ihara E, Nishioka K, Iboshi Y, Chinen T, Ochiai T, Akiho H, Nakamura K, Gotoda T, Ogawa Y.
PMID: 32434191 [PubMed - as supplied by publisher]


Effects of sDR5-Fc fusion protein on infant mice with ulcerative colitis via the TRAIL-DR5 pathway.
J Biol Regul Homeost Agents
Cai LJ, Wang MF, Wang XL, Zhu HF, Chen XZ.
PMID: 32425017 [PubMed - in process]


Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis.
J Immunol Res
Li X, Lee EJ, Gawel DR, Lilja S, Schäfer S, Zhang H, Benson M.
PMID: 32411805 [PubMed - in process]


Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis.
Mediators Inflamm
Camarillo GF, Goyon EI, Zuñiga RB, Salas LAS, Escárcega AEP, Yamamoto-Furusho JK.
PMID: 32410873 [PubMed - in process]


Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study.
PLoS One
Kunovszki P, Milassin Á, Gimesi-Országh J, Takács P, Szántó K, Bálint A, Farkas K, Borsi A, Lakatos PL, Szamosi T, Molnár T.
PMID: 32407408 [PubMed - in process]


Ulcerative colitis: Recent advances in the understanding of disease pathogenesis.
F1000Res
Porter RJ, Kalla R, Ho GT.
PMID: 32399194 [PubMed - in process]


Slit2/Robo1 Mitigates DSS-induced Ulcerative Colitis by Activating Autophagy in Intestinal Stem Cell.
Int J Biol Sci
Xie J, Li L, Deng S, Chen J, Gu Q, Su H, Wen L, Wang S, Lin C, Qi C, Zhang Q, Li J, He X, Li W, Wang L, Zheng L.
PMID: 32398956 [PubMed - in process]


Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.
Trials
Chen YM, Deng JM, Wen Y, Chen B, Hou JT, Peng B, Zhang SJ, Mi H, Jiang QL, Wu XL, Liu FB, Chen XL.
PMID: 32398112 [PubMed - in process]


Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study.
Yonsei Med J
Han M, Jung YS, Cheon JH, Park S.
PMID: 32390361 [PubMed - in process]


Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis.
Int J Colorectal Dis
Tang LL, Feng WZ, Cheng JJ, Gong YN.
PMID: 32388604 [PubMed - in process]


Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
Medicine (Baltimore)
Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H.
PMID: 32384473 [PubMed - indexed for MEDLINE]


Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
Am J Gastroenterol
Dulai PS, Battat R, Barsky M, Nguyen NH, Ma C, Narula N, Mosli M, Vande Casteele N, Boland BS, Prokop L, Murad MH, D, Feagan BG, Sandborn WJ, Jairath V, Singh S.
PMID: 32384283 [PubMed - as supplied by publisher]


Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis.
Evid Based Complement Alternat Med
Ding Y, Chen M, Wang Q, Gao L, Feng Y, Wang S, Song Z, Tong Z.
PMID: 32382313 [PubMed]


The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.
J Patient Cent Res Rev
Yarlas A, Maher S, Bayliss M, Lovley A, Cappelleri JC, Bushmakin AG, DiBonaventura MD.
PMID: 32377552 [PubMed]


Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
Clin Gastroenterol Hepatol
Cheng D, Cushing KC, Cai T, Ananthakrishnan AN.
PMID: 32371165 [PubMed - as supplied by publisher]


ACR Appropriateness Criteria® Crohn Disease.
J Am Coll Radiol
Expert Panel on Gastrointestinal Imaging., Kim DH, Chang KJ, Fowler KJ, Cash BD, Garcia EM, Kambadakone AR, Levy AD, Liu PS, Mace SE, Marin D, Moreno C, Peterson CM, Pietryga JA, Solnes LB, Weinstein S, Carucci LR.
PMID: 32370980 [PubMed - in process]


Efficacy of Serum Total Bilirubin in Predicting the Severity of Ulcerative Colitis: A Cross-Sectional Study.
Ann Clin Lab Sci
Zhang MH, Wang HG, Shi YT, Zhou JF, Yan W, Ma TH, Wu SN, Yang XZ.
PMID: 32366561 [PubMed - in process]


   
   Artikel 1 - 20 / 37372    Seite 1 von 1869  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1